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In memory of Marcos Vidal (1974-2016)
Ross Cagan1,* and Eyal Gottlieb2
With the untimely death of Marcos Vidal, we have lost a good friend
and a creative, brilliant colleague who made important contributions
to the field of cancer biology through fruit fly research. Marcos began
his research into Drosophila at Ross Cagan’s laboratory in 2003, first
at Washington University in St Louis and later at Mount Sinai Hospital
in New York. In 2009 Marcos was appointed as Research Group
Leader at the Beatson Institute for Cancer Research in Glasgow.
I (Ross) had just finished giving a talk in the Renal Division at
Washington University School of Medicine when a young scientist
approached me. Hewas a biochemist but liked the idea of using fruit
flies to study diseases. Marcos Vidal was an impressive young man
and I was excited to have him join the laboratory. A few days later a
woman approached with the same request. Julia Cordero assured me
that her relationship with Marcos would not be a problem, that they
were used to working together and that they never fought. I sat them
on opposite sides of the laboratory.
Marcos and Julia were a brilliant young couple who instantly
made the laboratory smart and fun. Marcos took up cancer research,
the second person to ever work on this disease in the laboratory. He
loved everything about conducting science and he was ambitious.
He worked crazy hours. With a laconic Argentinian accent, he kept
up a running science conversation that lasted until now. Julia
worked on separate topics and they lived balanced lives. Marcos
loved board sports from snowboarding to kite- and wind-surfing,
and was superb at them. Marcos and Julia made friends easily. The
Facebook postings and the emails we’ve received and the
conversations we’ve had over the past few days are a reminder of
just how much they are loved. We all rooted for their success
because they were really good people.
Marcos pushed the fly as a discovery platform further than almost
anybody else. He was enthusiastic to exploit the power of drug
screening. He had a feel for the organism and, perhaps most
importantly, he had a feel for what constituted an important biological
question. In 2005 he validated Vandetanib as a candidate therapeutic
for medullary thyroid carcinoma. The drug was approved in 2011 for
clinical use. He explored the role of Src in oncogenesis, providing
evidence and mechanisms that position metastasis as an immediate
early event, promoted at least in part by local cell interactions within
the epithelium. Later on, as an independent GroupLeader inGlasgow,
Marcos focused on the cancer-promoting role of the tumor
microenvironment and the immune system. Using the fruit fly as a
cancer model, Marcos demonstrated that the genetic composition of a
tumor is a key determinant as to whether tumor necrosis factor (TNF)
acts as a tumor-suppressing or tumor-promoting factor. He further
characterized the crosstalk between epithelial tumors and the innate
immune response, demonstrating that the TNF-Toll non-cell-
autonomous signaling cascade dictates tumor cell fate. Marcos used
the fruit fly cancer model creatively, and he did it with a style
unmistakably his own.
As a couple, Marcos and Julia were a true science power:
young and smart and handsome. In Glasgow, Marcos started out
as a Junior Group Leader at the Beatson Institute, becoming my
(Eyal) valued neighbor and peer. Julia helped him set up his
laboratory, and later started her own. They lived the lives of
young professionals, with an international twist. They worried
about keeping two leadership research positions, worried about
their two young children and whether Argentinians could adapt
to the Scottish weather. But they soon became central to the
Beatson Institute, got involved with the local community and
established successful professional and personal lives in
Scotland. Beyond his work in the lab, Marcos dedicated his
energy and free time to his family. He spent long, happy hours
passing his boarding and drawing skills to his son Lautaro, and
riding his bike with his daughter Mara.
Marcos fell ill 18 months ago and those extremely difficult
times were a testimony to the central role his family and friends
played in his life. Marcos worked as hard as he could to make a
recovery. He received tremendous support from his colleagues
and friends and, most of all, from Julia. Despite struggling with
his illness, Marcos sailed through his tenure review with flying
colors and, in July 2015, he became a Senior Research Group
Leader at the Beatson Institute and a Professor at the University
of Glasgow.
Marcos Vidal died on January 2, 2016. Julia, Lautaro and Mara
lost a warm-hearted, dedicated and loving husband and father; the
science community has lost a brilliant young scientist and a good
friend.
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